Patients who underwent cholecystectomy with either a usual care approach or a more restrictive selection strategy experienced a suboptimal reduction in abdominal pain.
The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
Misapplication of the guideline can put patient health and safety at risk.
The first generic naloxone nasal spray to treat opioid overdose has received approval from the US Food and Drug Administration.
An initial prescription of opioids for 4 to 7 days for the management of acute pain in the primary care setting was found to be sufficient.
Researchers found data to support psychological treatments to reduce the number of headaches and the headache index.
Many providers stopped initiating opioid therapy from July 2012 to December 2017.
Curtailing prescription opioid use has led to an increase in prescribing benzodiazepines to manage pain.
In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
Mindfulness-based cognitive therapy may represent a feasible and efficacious treatment for chronic low back pain.
